406 related articles for article (PubMed ID: 24952892)
1. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
[TBL] [Abstract][Full Text] [Related]
2. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.
Martino ME; de Villoria JG; Lacalle-Aurioles M; Olazarán J; Cruz I; Navarro E; García-Vázquez V; Carreras JL; Desco M
Ann Nucl Med; 2013 Aug; 27(7):600-9. PubMed ID: 23585159
[TBL] [Abstract][Full Text] [Related]
4. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
5. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
Perani D; Della Rosa PA; Cerami C; Gallivanone F; Fallanca F; Vanoli EG; Panzacchi A; Nobili F; Pappatà S; Marcone A; Garibotto V; Castiglioni I; Magnani G; Cappa SF; Gianolli L;
Neuroimage Clin; 2014; 6():445-54. PubMed ID: 25389519
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
8. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis.
Van Der Gucht A; Verger A; Guedj E; Malandain G; Hossu G; Yagdigul Y; Roch V; Poussier S; Maillard L; Karcher G; Marie PY
Ann Nucl Med; 2015 Dec; 29(10):921-8. PubMed ID: 26323854
[TBL] [Abstract][Full Text] [Related]
10. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
[TBL] [Abstract][Full Text] [Related]
11. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans.
Gispert JD; Pascau J; Reig S; Martínez-Lázaro R; Molina V; García-Barreno P; Desco M
Neuroimage; 2003 Jul; 19(3):601-12. PubMed ID: 12880791
[TBL] [Abstract][Full Text] [Related]
12. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
13. A statistical parametric mapping toolbox used for voxel-wise analysis of FDG-PET images of rat brain.
Nie B; Liu H; Chen K; Jiang X; Shan B
PLoS One; 2014; 9(9):e108295. PubMed ID: 25259529
[TBL] [Abstract][Full Text] [Related]
14. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
[TBL] [Abstract][Full Text] [Related]
15. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
16. Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
Van Der Gucht A; Verger A; Yagdigul Y; Poussier S; Joly L; Watfa G; Benetos A; Karcher G; Marie PY
Acta Radiol; 2015 Aug; 56(8):980-9. PubMed ID: 25085109
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
[TBL] [Abstract][Full Text] [Related]
18. Brain fluorodeoxyglucose (FDG) PET in dementia.
Kato T; Inui Y; Nakamura A; Ito K
Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
[TBL] [Abstract][Full Text] [Related]
19. The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis.
Gallivanone F; Della Rosa PA; Perani D; Gilardi MC; Castiglioni I;
Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):115-132. PubMed ID: 25479418
[TBL] [Abstract][Full Text] [Related]
20. A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.
Poljansky S; Ibach B; Hirschberger B; Männer P; Klünemann H; Hajak G; Marienhagen J
Eur Arch Psychiatry Clin Neurosci; 2011 Sep; 261(6):433-46. PubMed ID: 21207049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
